Diet influences survival after stage 3 colon cancer, Dana-Farber study finds

NCCN announces virtual tool for navigating guidelines

The National Comprehensive Cancer Network announces a new, interactive digital delivery format for the NCCN Clinical Practice Guidelines in Oncology.

June 27, 2025

Vol.51 No.25

Conversation with The Cancer Letter

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

June 20, 2025

Vol.51 No.24

By Otis W. Brawley and Paul Goldberg

Clinical Roundup

Study of retifanlimab in squamous cell carcinoma meets primary endpoint of PFS

Primary results from the phase III POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz), a humanized monoclonal antibody targeting programmed death receptor-1, in combination with carboplatin and paclitaxel (platinum-based chemotherapy) in adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal cancer who have not been previously treated with systemic chemotherapy, were published in The Lancet.

June 20, 2025

Vol.51 No.24

Cancer Policy

In “Bethesda Declaration,” NIH employees, Nobel laureates say Bhattacharya is favoring politics over U.S. science, health

NIH Director Jayanta Bhattacharya “prioritizes political momentum over human safety and faithful stewardship of public resources,” a group of Nobel laureates and over 300 NIH employees wrote in a letter.

AMA President Bobby Mukkamala, brain cancer survivor, says NIH research saved his life

In November 2024, Bobby Mukkamala was giving a routine talk to a group of physicians and medical students when his language suddenly became garbled. For a minute or two, he stopped making any sense.

Samir S. Taneja named head of Northwell Health’s urology service line

Samir S. Taneja was selected to lead Northwell Health’s urology service line. He was appointed senior vice president, Northwell’s system chair of urology, and chair of the Smith Institute for Urology at Northwell Health.

June 13, 2025

Vol.51 No.23

Diet influences survival after stage 3 colon cancer, Dana-Farber study finds

YOU MAY BE INTERESTED IN

NCCN announces virtual tool for navigating guidelines

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

Study of retifanlimab in squamous cell carcinoma meets primary endpoint of PFS

In “Bethesda Declaration,” NIH employees, Nobel laureates say Bhattacharya is favoring politics over U.S. science, health

AMA President Bobby Mukkamala, brain cancer survivor, says NIH research saved his life

Samir S. Taneja named head of Northwell Health’s urology service line

Renew today!

Subscriber content

Never miss an issue!

Login